Morning Overview on MSN

FDA pilots AI and real-time data reviews to speed some clinical trials

A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by ...
Nasdaq

Rezolute, Inc. Announces Late-Breaking Presentation of Phase 3 Study Data for Ersodetug at ENDO 2025

Rezolute, Inc., a company focused on treating hypoglycemia caused by hyperinsulinism, announced that its abstract for a Phase 3 study of its drug Ersodetug will be presented at ENDO 2025 in San ...